Q BioMed Inc. (QBIO) financial statements (2022 and earlier)

Company profile

Business Address 366 MADISON AVE.
NEW YORK, NY 10017
State of Incorp. NV
Fiscal Year End November 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3441771732,6848252,395131
Cash and cash equivalents3441771732,6848251,469131
Other undisclosed cash, cash equivalents, and short-term investments     926 
Receivables80      
Prepaid expense   133  
Other undisclosed current assets354618  (926) 
Total current assets:4592231902,6978271,469131
Noncurrent Assets
Intangible assets, net (including goodwill)350400450500293293231
Intangible assets, net (excluding goodwill)350400450500293293231
Other undisclosed noncurrent assets    (293)(293)(231)
Total noncurrent assets:350400450500   
TOTAL ASSETS:8096236403,1978271,469131
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,3701,6031,98839246449891
Accounts payable1,345722652    
Accrued liabilities9548381,146  168 
Interest and dividends payable714319030 49 
Other undisclosed accounts payable and accrued liabilities   36346428191
Debt3,053923,243  100296
Due to related parties72488871 
Other undisclosed current liabilities00 30 2,612 
Total current liabilities:5,4951,6995,2384294713,280387
Noncurrent Liabilities
Liabilities, other than long-term debt, including:   2,873 232 
Other undisclosed liabilities, other than long-term debt   2,873 232 
Other undisclosed noncurrent liabilities  447    
Total noncurrent liabilities:  4472,873 232 
Total liabilities:5,4951,6995,6863,3034713,512387
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,685)(1,075)(5,045)(106)356(2,043)(256)
Common stock292420141299
Additional paid in capital53,33647,65637,32931,99423,1876,249866
Accumulated deficit(64,127)(55,886)(42,394)(32,114)(22,843)(8,302)(1,130)
Other undisclosed stockholders' equity attributable to parent6,0777,130     
Total stockholders' equity:(4,685)(1,075)(5,045)(106)356(2,043)(256)
TOTAL LIABILITIES AND EQUITY:8096236403,1978271,469131

Income statement (P&L) ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
Revenues19630     
Cost of revenue(247)(326)     
Cost of goods and services sold (324)     
Gross profit:(51)(296)     
Operating expenses(7,337)(12,849)(8,020)(9,020)(12,372)(6,347)(952)
Other operating expense, net
(Other Expenses)
    (2,170)(825)(134)
Operating loss:(7,389)(13,145)(8,020)(18,290)(29,083)(14,343)(1,087)
Nonoperating expense
(Other Nonoperating expense)
  (2,260)    
Interest and debt expense(41)(31)(1,460)(526)76(481)(21)
Other undisclosed income from continuing operations before equity method investments, income taxes 31     
Loss from continuing operations before equity method investments, income taxes:(7,429)(13,145)(11,740)(18,816)(29,007)(14,824)(1,108)
Other undisclosed income from continuing operations before income taxes41      
Loss before gain (loss) on sale of properties:(7,389)(13,145)(11,740)(18,816)(29,007)(14,824)(1,108)
Other undisclosed net income  1,46019,80714,46515,92421
Net income (loss):(7,389)(13,145)(10,280)990(14,542)1,100(1,087)
Other undisclosed net loss attributable to parent(852)(347) (10,261) (8,272) 
Net loss attributable to parent:(8,241)(13,492)(10,280)(9,271)(14,542)(7,172)(1,087)
Preferred stock dividends and other adjustments(501)(858)     
Other undisclosed net income available to common stockholders, basic   23,77129,04214,372 
Net income (loss) available to common stockholders, diluted:(8,741)(14,350)(10,280)14,50014,5007,200(1,087)

Comprehensive Income ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
Net income (loss):(7,389)(13,145)(10,280)990(14,542)1,100(1,087)
Comprehensive income (loss), net of tax, attributable to parent:(7,389)(13,145)(10,280)990(14,542)1,100(1,087)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: